10X Genomics Inc (TXG) Annual Income Statement (USD)
TXG Quarterly Financials (USD)
Frequently Asked Questions About 10X Genomics Inc (TXG) Stock
10X Genomics Inc's (TXG) last reported annual revenue was USD 618.73 Million.
10X Genomics Inc's (TXG) annual revenue growth rate based on the revenue reported in the past 5 years is : 33.43%
10X Genomics Inc's(TXG) is not profitable as of its last reported annual financials.
The net profit margin for 10X Genomics Inc's(TXG) from its laster reported year is -41.23%
The return on equity (ROE) for 10X Genomics Inc's(TXG) from its last reported annual financials is : N/A
The return on assets (ROA) for 10X Genomics Inc's(TXG) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for 10X Genomics Inc's(TXG) from its last reported annual financials is : N/A
The Debt to Equity ratio for 10X Genomics Inc's(TXG) from its last reported annual financials is : N/A
The dividend yield for 10X Genomics Inc's(TXG) from its laster reported year is N/A
10X Genomics Inc's(TXG) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TXG !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
